Gallium Ga 68 dotatate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	5156	1051369-72-2

Description:

Molecule	Description
Synonyms: Gallium Ga 68 dotatate (68Ga)gallium dotatate netspot	A radioactive diagnostic agent used for POSITRON EMISSION TOMOGRAPHY (PET) imaging of SOMATOSTATIN RECEPTOR positive neuroendocrine tumors and malignant abdominal paraganglioma. Molecular weight: 1500.54 Formula: C65H87GaN14O19S2 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: 468.57 ALOGS: ROTB: None

Molecule

Description

Synonyms:

Gallium Ga 68 dotatate
(68Ga)gallium dotatate
netspot

A radioactive diagnostic agent used for POSITRON EMISSION TOMOGRAPHY (PET) imaging of SOMATOSTATIN RECEPTOR positive neuroendocrine tumors and malignant abdominal paraganglioma.

Molecular weight: 1500.54
Formula: C65H87GaN14O19S2
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 468.57
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
June 1, 2016	FDA	ADVANCED ACCELERATOR APPLICATIONS USA INC

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Scan gallium abnormal	143.31	86.65	13	182	20	79744173
Nausea	125.47	86.65	54	141	957142	78787051

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Positron emission tomography	indication	82918005

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Exclusivity date	Description
2.1-5.5mCi/ML	NETSPOT	AAA USA INC	N208547	June 1, 2016	RX	POWDER	INTRAVENOUS	June 1, 2023	FOR USE AFTER RADIOLABELING WITH GA 68, WITH POSITRON EMISSION TOMOGRAPHY (PET) FOR LOCALIZATION OF SOMATOSTATIN RECEPTOR POSITIVE NEUROENDOCRINE TUMORS (NETS) IN ADULT AND PEDIATRIC PATIENTS.

Bioactivity Summary:

None

External reference:

ID	Source
4038246	VANDF
C1742831	UMLSCUI
CHEMBL4297340	ChEMBL_ID
131634491	PUBCHEM_CID
DB13925	DRUGBANK_ID
676679	RXNORM
241192	MMSL
C513399	MESH_SUPPLEMENTAL_RECORD_UI

Pharmaceutical products:

None